Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01142817 · ClinicalTrials.gov registry record

Metabolic and Psychological Changes Associated With Menopause Among Women With HIV

A clinical trial of HIV Infections and Menopause, sponsored by Massachusetts General Hospital.

Completed
Registry status
66
Enrollment target
1
Study location

NCT01142817 is a study of HIV Infections and Menopause that has completed, run by Massachusetts General Hospital. The registered enrollment target is 66 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01142817, a study of HIV Infections and Menopause, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
66 participants
Enrollment target
1
Study location

Study Summary

This study will investigate the prevalence and extent of both metabolic and psychosocial changes associated with the menopause transition over 1 year among women with HIV compared to women without HIV of similar age, weight, menstrual status, and ethnic background. It is hypothesized that HIV positive women will demonstrate increased abdominal fat, abnormal cholesterol and blood sugar levels, reduced bone density, and greater psychosocial challenges than HIV negative women during the menopause transition.

Conditions Studied

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2010-06
Est. Completion 2013-05

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT01142817

The ClinicalTrials.gov registry entry for NCT01142817 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (85% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT01142817 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01142817 about?

NCT01142817 is a clinical study titled "Metabolic and Psychological Changes Associated With Menopause Among Women With HIV". This study will investigate the prevalence and extent of both metabolic and psychosocial changes associated with the menopause transition over 1 year among women with HIV compared to women without HIV of similar age, weight, menstrual status, and ethnic background. It is hypothesized that HIV positi...

What is the current status of trial NCT01142817?

This trial is currently completed. The enrollment target is 66 participants. The study started on 2010-06. Estimated completion is 2013-05.

What conditions does trial NCT01142817 study?

This clinical trial studies the following conditions: HIV Infections, Menopause.

Who is sponsoring clinical trial NCT01142817?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01142817 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.